The stock is on the nasdaq top gainers list today on Acquisition news, currently trading at 9.3, up 6.49, gaining 226.92% on volume of over 28 Million shares as of this report.

Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, today announced ...

Several years ago, NSYNC’s Lance bass noticed he felt run down. Doctors diagnosed him with type 2 diabetes but drugs didn't ...

Immunic, Inc. to Participate in Investor Conference in December NEW YORK, November 26, 2024 – Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally ...

We recently compiled a list of the 10 Oversold Healthcare Stocks To Invest In. In this article, we are going to take a look ...

With over 18 years of experience assisting over 500 client partners and a sizable family of 70+ trusted brands, IBN has ...

Here we share a list of abnormalities in nails that can showcase health issues. Some changes may require immediate medical ...

Roche RHHBY announced that it will acquire clinical-stage biopharmaceutical company Poseida Therapeutics, Inc. PSTX for $9 ...

Imkeldi is a new formulation of imatinib approved as a strawberry-flavored, shelf-stable liquid designed to be more appealing ...

The lack of knowledge about the benefits of human genomics for public and individual health, together with the scarcity of qualified professionals and ...

Yesterday, the story ended exactly as I and many others knew it would — with the company’s experimental drug for Alzheimer’s ...

Whether you’re just starting or looking for additional inspiration, learn more about how these 10 critical lifestyle habits can help you on your weight loss journey.